Drug intelligence / Profile preview

potassium aspartate + magnesium aspartate

Development stage
Unknown
Lead developer
Biosintez
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Asparcam is a fixed-dose combination of potassium aspartate and magnesium aspartate, widely used in Eastern Europe and post-Soviet countries as a metabolic and electrolyte-balancing agent. It is designed to rapidly replenish potassium and magnesium deficiencies, thereby supporting myocardial metabolism, regulating cardiac rhythm, and maintaining electrolyte homeostasis. The aspartate anion acts as an endogenous carrier that facilitates the transport of potassium and magnesium ions across cell membranes into the intracellular space. Asparcam is commonly used as an adjuvant therapy for coronary heart disease, heart failure, and various cardiac arrhythmias, including those induced by cardiac glycoside overdose.

Brand names
AsparaAsparcamAsparcam-FarmakAsparcam-LAsparkamPananginPanangin ForteSpartaseTrophicard
Other names
potassium and magnesium aspartatepotassium asparaginate + magnesium asparaginatepotassium L-aspartate + magnesium L-aspartatepotassium magnesium aspartate
02

Targets

CaV (Voltage-gated calcium channel protein complex)Kir (Inward-rectifier potassium channels)ATP1A (Sodium/potassium-transporting ATPase)

Beyond the preview

Go deeper on potassium aspartate + magnesium aspartate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium aspartate + magnesium aspartate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call